News | June 03, 2024
PharmaLytica 2024: India exported US$ 27.8 billion worth of drugs in FY 2023-24
The Indian pharmaceutical industry is projected to reach US$ 130 billion by 2030
The Indian pharmaceutical industry is projected to reach US$ 130 billion by 2030
The US Generics market has been witnessing significant pricing pressure leading to significant losses at Jubilant Cadista since FY2022 onwards.
These facilities are commissioned by Aurobindo's wholly own subsidiary: Lyfius Pharma Private Limited, Qule Pharma Private Limited, Eugia Steriles Private Limited and Auroactive Pharma Private Limited.
Ukrainian marketing approvals for paclitaxel, oxaliplatin and irinotecan mark a significant milestone in the company’s global expansion strategy
Sadhana Nitro Chem's plant is the second plant in the world to manufacture pAP from Nitrobenzene
The company recently received CEP certificate approval for Losartan Potassium by EDQM
Revenue from Operations stood at Rs. 2,607 crore, 25% YoY growth. Domestic revenue at Rs. 2,400 crore, 20% YoY growth and export revenue at Rs. 207 crore, 118% YoY growth
Aarti Drugs has reported total income of Rs. 607.61 crores during the period ended December 31, 2023
The company has secured two orders for male condoms from CMSS worth Rs. 9.65 crores and Rs. 6.58 crores respectively
The company makes its maiden entry into Azerbaijan’s pharmaceutical market
Subscribe To Our Newsletter & Stay Updated
